The dexamethasone suppression test in acute mania.

Area of Science:

• Psychiatry
• Neuroendocrinology
• Clinical Neuroscience

Background:

• The dexamethasone suppression test (DST) is a neuroendocrine challenge used to assess hypothalamic-pituitary-adrenal (HPA) axis function.
• Abnormal DST results have been associated with various psychiatric disorders, including depression and bipolar disorder.

Purpose of the Study:

• To investigate the utility of the dexamethasone suppression test (DST) in newly admitted manic patients.
• To explore potential correlations between DST results and clinical characteristics or treatment outcomes in mania.

Main Methods:

• Administered the dexamethasone suppression test (DST) to 40 newly admitted patients diagnosed with mania.
• Analyzed DST results for abnormal escape from suppression.
• Correlated DST findings with demographic data, clinical history, and discharge medication.

Main Results:

• Sixty percent (24 out of 40) of manic patients exhibited abnormal escape from suppression on the DST.
• No significant correlations were found between DST results and sex, age, age of onset, family history, psychosis, or hospitalization duration.
• Patients with abnormal DST non-suppression were significantly more likely to be discharged receiving lithium monotherapy compared to suppressors.

Conclusions:

• The dexamethasone suppression test (DST) may serve as a potential biomarker for treatment response in manic episodes.
• Abnormal DST non-suppression in mania might predict a favorable response to lithium treatment.
• Further research is warranted to elucidate the predictive value of DST in managing bipolar disorder.